Page last updated: 2024-08-26

droxidopa and Chronic Illness

droxidopa has been researched along with Chronic Illness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Freeman, R; Goldstein, DS; Holmes, C; Kaufmann, H1
Chiba, M; Ito, T; Nishino, K; Sasaki, T; Takahashi, K1

Trials

2 trial(s) available for droxidopa and Chronic Illness

ArticleYear
Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2004, Volume: 14, Issue:6

    Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Blood Pressure; Catecholamines; Chronic Disease; Diet; Droxidopa; Female; Half-Life; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine

2004
The norepinephrine precursor L-threo-3,4-dihydroxyphenylserine facilitates motor recovery in chronic stroke patients.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2001, Volume: 8, Issue:6

    Topics: Adult; Aged; Antiparkinson Agents; Cerebrovascular Circulation; Chronic Disease; Droxidopa; Female; Functional Laterality; Gait; Humans; Iofetamine; Male; Middle Aged; Motor Activity; Norepinephrine; Radiopharmaceuticals; Recovery of Function; Stroke; Tomography, Emission-Computed, Single-Photon

2001